Unique ID issued by UMIN | UMIN000039160 |
---|---|
Receipt number | R000044230 |
Scientific Title | Study on effects of long-tern ingestion of beverages containing lactic acid bacterium producing substance on body fat. |
Date of disclosure of the study information | 2020/01/20 |
Last modified on | 2020/07/15 15:28:18 |
Study on effects of long-tern ingestion of beverages containing lactic acid bacterium producing substance on body fat.
Effects of beverages containing lactic acid bacterium producing substance on body fat.
Study on effects of long-tern ingestion of beverages containing lactic acid bacterium producing substance on body fat.
Effects of beverages containing lactic acid bacterium producing substance on body fat.
Japan |
obesity
Endocrinology and Metabolism |
Others
NO
To investigate the effects of long-tern ingestion of beverages containing lactic acid bacterium producing substance on suppression of body fat.
Safety,Efficacy
Visceral fat area
Body weight, Body fat percentage, BMI, Waist length, Blood pressure, Serum cholesterol, Serum triglyceride, Blood glucose level, GOT, GPT, Gamma-GTP, White blood cell count, Red blood cell count, Hemoglobin, Hematocrit, Platelet count, LD, Total bilirubin, ALP, HbA1c, Total protein, Albumin, Urea nitrogen, Creatinine, Uric acid
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
Food |
The subjects ingested the placebo meal for eight weeks
The subjects ingested the active meal for eight weeks
20 | years-old | <= |
80 | years-old | > |
Male and Female
1) Healthy male and female between 20 and 80 years old
2) Visceral fat area 80 cm2 or more, body mass index between 23 and 30
3) Individuals who can refrain from over drinking and over eating during the test period
4) Individuals who understand the purpose and contents of the experiment
1)Individuals taking drugs affect lipid metabolism
2)Those who can not stop taking supplements or health foods that may affect lipid metabolism during the test period
3)Subjects who are contracting or treating severe diabetes and kidney and/or liver diseases
4)Those who have been diagnosed with familial hyperlipidemia
5)Individuals with a chronic diseases
6)Those who can not stop taking a large amount of lactic acid bacteria beverage during the test period
7)Pregnant women, or women with intending to become pregnant, and lactating woman
8)Individuals participating or intending to participate in other drug administration tests
9)Individuals judged by the doctor to be unsuitable
40
1st name | Kaunari |
Middle name | |
Last name | Tanaka |
Univercity of Nagasaki
Faculty of Nursing and Nutrition
851-2195
1-1-1 Manabino, Nagayo-cho, Nishisosnogi-gun, Nagasaki, Japan,
0958135216
katanaka@sun.ac.jp
1st name | Hideki |
Middle name | |
Last name | Ito |
Univercity of Nagasaki
Regional Partnership Center
851-2195
1-1-1 Manabino, Nagayo-cho, Nishisosnogi-gun, Nagasaki, Japan
0958135216
katanaka@sun.ac.jp
Univercity of Nagasaki
Biogenomics Co., Ltd.
Profit organization
Univercity of Nagasaki
1-1-1Manabino,Nagayo-cho,Nishisonogi-gun,Nagasaki,Japan,851-2195
0958135216
katanaka@sun.ac.jp
NO
2020 | Year | 01 | Month | 20 | Day |
Unpublished
50
Completed
2019 | Year | 12 | Month | 14 | Day |
2019 | Year | 11 | Month | 30 | Day |
2020 | Year | 01 | Month | 11 | Day |
2020 | Year | 03 | Month | 09 | Day |
2020 | Year | 01 | Month | 15 | Day |
2020 | Year | 07 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044230